Nanocan Therapeutics Corp — Form D
Nanocan Therapeutics Corp of NATIONAL HARBOR, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-27. The offering totals $1.4M, of which $1.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-08-27
- Form: D
- Accession: 0001820532-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.1M
- Remaining: $275K
- Investors: 6
- Date of first sale: 2020-07-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374216
Issuer
- Name: Nanocan Therapeutics Corp
- CIK: 0001820532
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 137 NATIONAL PLZ STE 300, NATIONAL HARBOR, MD, 20745
- Phone: (202) 258-1591
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Eric Broyles | Director | Princeton, NJ |
| Eric Broyles | Executive Officer | Princeton, NJ |
| Jacques Walker | Executive Officer | Princeton, NJ |
| Dave P Krasne | Executive Officer | NATIONAL HARBOR, MD |
| Eric C Broyles | Director | NATIONAL HARBOR, MD |
| Eric C Broyles | Executive Officer | NATIONAL HARBOR, MD |
| Jacques P Walker | Director | NATIONAL HARBOR, MD |
| Jacques P Walker | Executive Officer | NATIONAL HARBOR, MD |
Other filings by this issuer (1)
More